Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification?

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Autoimmunity

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/08916939508993337PMID 7578859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis.

  1994cited by this paper
• Large vessel occlusive disease associated with CREST syndrome and scleroderma.

  1993cited by this paper
• Antiphospholipid syndrome in scleroderma.

  1993cited by this paper
• Antiphospholipid antibodies in mixed connective tissue disease

  1992cited by this paper
• Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series.

  1992cited by this paper
• Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion.

  1992cited by this paper
• Pulmonary hypertension in MCTD: Report of two cases with anticardiolipin antibody

  1992cited by this paper
• Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.

  1991cited by this paper
• The pathogenesis of scleroderma (systemic sclerosis, SSc).

  1991cited by this paper
• The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response.

  1990cited by this paper
• Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis.

  1990cited by this paper
• The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response.

  1990cited by this paper
• Immunological abnormalities in a group of patients with limited cutaneous systemic sclerosis and prominent vascular disease.

  1990cited by this paper
• Large vessel arterial thrombosis in systemic sclerosis with antiphospholipid antibodies.

  1990cited by this paper
• Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions.

  1990cited by this paper
• Large vessel arterial thrombosis in systemic sclerosis associated with antiphospholipid antibodies.

  1990cited by this paper
• Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease.

  1989cited by this paper
• Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant

  1989cited by this paper
• Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.

  1989cited by this paper
• Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

  1989cited by this paper
• Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases.

  1989cited by this paper
• The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity.

  1988cited by this paper
• Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

  1988cited by this paper
• Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.

  1988cited by this paper
• Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.

  1988cited by this paper
• Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease.

  1988cited by this paper
• Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

  1988cited by this paper
• Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

  1988cited by this paper
• Anti-cardiolipin antibodies in progressive systemic sclerosis (PSS)

  1987cited by this paper
• Anticardiolipin antibodies in rheumatoid arthritis.

  1987cited by this paper
• Syndrome of the black swan.

  1987cited by this paper
• Anticardiolipin antibodies in systemic sclerosis.

  1986cited by this paper
• Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.

  1986cited by this paper
• Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant.

  1986cited by this paper
• The anticardiolipin syndrome.

  1985cited by this paper
• Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin.

  1984cited by this paper
• Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.

  1984cited by this paper
• African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages.

  1984cited by this paper
• “Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation

  1982cited by this paper
• Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis.

  1982cited by this paper
• Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis.

  1981cited by this paper
• Primer of biostatistics : statistical software program version 6.0

  1981cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Vascular disease in progressive systemic sclerosis (scleroderma).

  1970cited by this paper

• Relationship between cutaneous polyarteritis nodosa (cPAN) and macular lymphocytic arteritis (MLA): Blinded histologic assessment of 35 cPAN cases.

  2015cites this paper
• Epidural spinal tumor and periaortitis as rare complications of Wegener’s granulomatosis

  2011cites this paper
• Epidural spinal tumor and periaortitis as rare complications of Wegener's granulomatosis

  2011cites this paper
• EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

  2010cites this paper
• Antineutrophil cytoplasmic antibodies

  2006cites this paper
• The clinical spectrum of primary renal vasculitis.

  2005cites this paper
• [Treatment of vasculitis without antineutrophil cytoplasmic autoantibodies].

  2001cites this paper
• [Neuropathy due to necrotizing vasculitis: a study of the clinical anatomy, neurophysiological characteristics, and clinical course of the disorder in 27 patients].

  2001cites this paper
• [Classification of vasculitis].

  2001cites this paper
• Purpuras vasculaires

  1999cites this paper
• Purpuras vasculaires

  1997cites this paper
• Anti‐native and recombinant myeloperoxidase monoclonals and human autoantibodies

  1997cites this paper
• POLYARTERITIS NODOSA, MICROSCOPIC POLYANGIITIS, SYNDROME: CLINICAL ASPECTS, NEUROLOGIC MANIFESTATIONS, AND TREATMENT AND CHURG-STRAUSS

  1997cites this paper
• Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment.

  1997cites this paper